Silo Pharma (SILO) vs SciSparc (SPRC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Silo Pharma is the larger company by market cap ($3.0 million vs $2.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SILO | SPRC |
|---|---|---|
| Share price | $1.47 | $4.47 |
| Market cap | $3.02M | $2.60M |
| 1-day change | +1.38% | +0.90% |
| P/E ratio (TTM) | — | 0.02 |
| EPS (TTM) | $-4.26 | $248.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.43 | $43.65 |
| 52-week low | $1.30 | $2.98 |
| Distance from 52-week high | -85.90% | -89.76% |
| Average volume | 110.63K | 179.62K |
| Shares outstanding | 2.05M | 580.97K |
| Employees | 3 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Silo Pharma
SILO stock →Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About SciSparc
SPRC stock →SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
SILO vs SPRC FAQ
Which is bigger, Silo Pharma or SciSparc?
Silo Pharma (SILO) is larger, with a market capitalization of $3.02M compared with $2.60M for SciSparc (SPRC).
Are Silo Pharma and SciSparc in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.